NASDAQ Composite Rises 1.49% This Week to 17948.32 — Data Talk
The NASDAQ Composite Index is up 264.34 points or 1.49% this week to 17948.32
--Up for two consecutive weeks
--Up 1257.49 points or 7.53% over the last two weeks
--Largest two-week point gain since the week ending March 25, 2022
--Largest two-week percentage gain since the week ending Nov. 10, 2023
--Up four of the past six weeks
--Today it is down 65.66 points or 0.36%
--Largest one-day point and percentage decline since Monday, Sept. 16, 2024
--Down two of the past three trading days
--Off 3.75% from its record close of 18647.45 hit Wednesday, July 10, 2024
--Up 60.82% from the Election Day close of 11160.57 on Tuesday, Nov. 3, 2020
--Up 33.37% from the Inauguration Day close of 13457.25 on Wednesday, Jan. 20, 2021
--Off 3.75% from its 52-week high of 18647.45 hit Wednesday, July 10, 2024
--Up 42.50% from its 52-week low of 12595.61 hit Thursday, Oct. 26, 2023
--Rose 35.85% from 52 weeks ago
--Off 3.75% from its 2024 closing high of 18647.45 hit Wednesday, July 10, 2024
--Up 23.69% from its 2024 closing low of 14510.30 hit Thursday, Jan. 4, 2024
--Month-to-date it is up 1.32%
--Year-to-date it is up 2936.97 points or 19.56%
Data based on preliminary market closing values
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 20, 2024 16:29 ET (20:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk